KMTS KESTRA MEDICAL TECHNOLOGIES...

Nasdaq www.kestramedical.com


$ 22.52 $ 0.39 (1.73 %)    

Tuesday, 14-Oct-2025 16:43:39 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 22.97
$ 22.29
$ 23.42 x 2
$ 24.18 x 5
$ 21.94 - $ 23.02
$ 13.25 - $ 27.71
528,272
na
1.18B
$ 0.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-12-2025 07-31-2025 10-Q
2 07-17-2025 04-30-2025 10-K
3 04-17-2025 01-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) raises FY2026 sales outlook from $85.000 million to $88.000 million vs $85.074 million estim...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.50) per share which beat the analyst consensus estimate of ...

Core News & Articles

Wells Fargo analyst Larry Biegelsen maintains Kestra Medical Techs (NASDAQ:KMTS) with a Overweight and lowers the price targ...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.15) per share which missed the analyst consensus estimate o...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) FY2026 Revenue expected to be more than $85.000M vs $82.972M Est

Core News & Articles

Kestra Medical Techs (NASDAQ: KMTS) sees FY2026 sales of $85.000 million vs $82.972 million analyst estimate.

Core News & Articles

Goldman Sachs analyst David Roman maintains Kestra Medical Techs (NASDAQ:KMTS) with a Neutral and lowers the price target fr...

Core News & Articles

Fiscal Year 2025 Revenue OutlookKestra expects revenue for fiscal year ending April 30, 2025 to be in the range of $58.0 millio...

Core News & Articles

Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(1.25) per share. This is a 5.93 percent decrease over losses ...

Core News & Articles

Wolfe Research analyst Mike Polark initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Outperform rating and ann...

Core News & Articles

Wells Fargo analyst Larry Biegelsen initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and an...

Core News & Articles

Stifel analyst Rick Wise initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Buy rating and announces Price Targ...

Core News & Articles

Goldman Sachs analyst David Roman initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Neutral rating and announc...

Core News & Articles

Piper Sandler analyst Matt O'Brien initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION